EUCanScreen Course on Upper GI Endoscopy: How to Improve Your Cancer Detection Rate
The course includes asynchronous webinars, peer case assessments, an interactive webinar, and a two-day in-person module in Porto or Kaunas.
Detection Rate
This blended-learning course was designed for European gastroenterologists involved in clinical training or leadership in gastric cancer screening or early diagnosis, aiming to enhance the quality and reporting of upper GI endoscopy (WP11.4). Learn from leading experts, gain up-to-date, evidence-based knowledge, and improve patient care by increasing detection rates and enhancing reporting quality.
Course Structure
The course will be delivered in three editions. Each edition includes asynchronous webinars, peer assessment of endoscopy cases, an interactive (synchronous) webinar, and a two-day face-to-face module with lectures and workshops. The face-to-face sessions will be held in Porto (1st and 3rd editions) or Kaunas (2nd edition).
– First Edition
- Asynchronous webinars: 3 November – 15 January 2026
- Peer assessment: 15 December 2025 – 15 January 2026
- Interactive webinar: February 2026 (to be defined)
- Face-to-face course (2 days): 19 – 20 March 2026, Porto, Portugal
– Second Edition (to be confirmed)
- Asynchronous webinars: February – April 2026
- Peer assessment: April 2026
- Interactive webinar: May 2026
- Face-to-face course (2 days): June 2026, Kaunas, Portugal
– Third Edition (to be confirmed)
- Asynchronous webinars: October – December 2026
- Peer assessment: December 2026
- Interactive webinar: January 2027
- Face-to-face course (2 days): February 2027, Porto, Portugal
Applications
No tuition fees | Travel & accommodation may be funded
Applications open 13 August – 30 September 2025. [Apply here].
#EuCanScreen #CancerScreening #HealthCare #CancerPrevention #Endoscopy #CancerDetectionRate #GastricCancer #WP11
🔗 Please don’t forget to Subscribe to EuCanScreen Newsletter! 💪
Subscribe to our newsletter to get news and updates.
Subscribe to our newsletter to get news and updates.
Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Health and Digital Executive Agency (HADEA). Neither the European Union nor HADEA can be held responsible for them.
The general objective of EUCanScreen is to assure sustainable implementation of high-quality screening for breast, cervical and colorectal cancers, as well as implementation of the recently recommended screening programs – for lung, prostate and gastric cancers. EUCanScreen will facilitate the reduction of cancer burden and achieving equity across the EU.
This project has received funding from the European Union’s EU4HEALTH Programme under the Grant Agreement no 101162959
